ProfileGDS4132 / 226110_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 86% 86% 82% 80% 86% 86% 77% 90% 87% 86% 89% 86% 89% 90% 84% 90% 88% 83% 80% 89% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101332.53486
GSM201543Muscle PCOS pioglitazone 121320.32686
GSM201544Muscle PCOS pioglitazone 161305.07882
GSM201545Muscle PCOS pioglitazone 201291.78880
GSM201829Muscle PCOS pioglitazone 231359.81786
GSM201830Muscle PCOS pioglitazon 251347.05986
GSM201831Muscle PCOS pioglitazone 271260.52577
GSM201832Muscle PCOS pioglitazone 31437.55390
GSM201833Muscle PCOS pioglitazone 41362.53387
GSM201834Muscle PCOS pioglitazone 81364.54386
GSM201835Muscle PCOS after pioglitazone 102415.00989
GSM201836Muscle PCOS after pioglitazone 122363.07486
GSM201837Muscle PCOS after pioglitazone 162406.54189
GSM201838Muscle PCOS after pioglitazone 202480.95390
GSM201839Muscle PCOS after pioglitazone 232326.49784
GSM201840Muscle PCOS after pioglitazone 252463.59890
GSM201841Muscle PCOS after pioglitazone 272384.30588
GSM201842Muscle PCOS after pioglitazone 32284.19283
GSM201843Muscle PCOS after pioglitazone 42280.33580
GSM201844Muscle PCOS after pioglitazone 82436.06189